AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2013
Jan 17, 2013
3174_iss_2013-01-17_a69a1e2c-3ed7-46f6-80ec-d4d1aae38f02.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension org nr 516401-6775
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 534,111 |
| Voting rights | 534,111 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 16/01/2013 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 545,443 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 545,443 |
| Percentage | |
| Directly held shares | 5.04 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.04 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Group total holdings
Voting rights 545,443 Percentage of voting rights 5.04
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringstagarna själva som via fullmakt placerar/omplacerar försäkringskapitalet.
Published
17/01/2013 16:42
Contact
Name Tanya Forsstedt Phone 08-56225737 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report (ESEF)
2026
Apr 17
Regulatory Filings
2026
Mar 13